Serum concentrations of insulin-like growth factor-binding protein 5 in Crohn’s disease

Table 1 Baseline characteristics of the study population n (%)

	Crohn’s disease	Healthy controls
	(n = 42)	(n = 20)
Age, mean ± SD (yr)	38.7 ± 13.9	38.4 ± 8.7
Gender
Female	20 (47.6)	10 (50)
Male	22 (52.4)	10 (50)
Disease localization		-
Ileum	9 (21.4)
Colon	2 (4.8)
Ileum + colon	31 (73.8)
Medical treatment		-
None	9 (21.4)
Corticosteroids	1 (2.4)
5-aminosalicylate	8 (19)
Azathioprine	33 (78.6)
Sulfasalazine	1 (2.4)
More than one drug	23 (54.8)
Median disease duration (yr) (IQR)	1.2 (0.17)	-
Prior intestinal resection	18 (42.9)	-

IQR: Interquartile range.